FDA Recalls Irbesartan Due to Cancer Risk Concerns

The United States Food and Drug Administration (FDA) has issued several recalls for Irbesartan, a commonly prescribed blood pressure medication, due to the discovery of a chemical linked to cancer. Patients across the country who relied on this medication are now left wondering if their health has been put at risk. If you or someone …